BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA
Departamento
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (8)
2022
-
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
Viruses, Vol. 14, Núm. 9
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2012
-
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
International Journal of Cancer, Vol. 131, Núm. 2, pp. 387-395
2009
2008
-
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Immunogenetics, Vol. 60, Núm. 8, pp. 439-447
-
HLA class I expression in metastatic melanoma lesions determines the progression/regression of the metastases in response to immunotherapy
TISSUE ANTIGENS
2007
-
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination
Cancer Immunology, Immunotherapy, Vol. 56, Núm. 5, pp. 709-717